Edwards Lifesciences Corporation

WBAG:EWLS Stock Report

Market Cap: €39.9b

Edwards Lifesciences Management

Management criteria checks 2/4

Edwards Lifesciences' CEO is Bernard Zovighian, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is $12.87M, comprised of 7.6% salary and 92.4% bonuses, including company stock and options. directly owns 0.012% of the company’s shares, worth €4.84M. The average tenure of the management team and the board of directors is 5.2 years and 4.5 years respectively.

Key information

Bernard Zovighian

Chief executive officer

US$12.9m

Total compensation

CEO salary percentage7.6%
CEO tenure1.5yrs
CEO ownership0.01%
Management average tenure5.2yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bernard Zovighian's remuneration changed compared to Edwards Lifesciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$2b

Jun 30 2024n/an/a

US$2b

Mar 31 2024n/an/a

US$1b

Dec 31 2023US$13mUS$973k

US$1b

Sep 30 2023n/an/a

US$1b

Jun 30 2023n/an/a

US$1b

Mar 31 2023n/an/a

US$1b

Dec 31 2022US$3mUS$642k

US$2b

Compensation vs Market: Bernard's total compensation ($USD12.87M) is above average for companies of similar size in the Austrian market ($USD4.34M).

Compensation vs Earnings: Bernard's compensation has increased by more than 20% in the past year.


CEO

Bernard Zovighian (56 yo)

1.5yrs

Tenure

US$12,869,020

Compensation

Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...


Leadership Team

NamePositionTenureCompensationOwnership
Bernard Zovighian
CEO & Director1.5yrsUS$12.87m0.012%
€ 4.8m
Scott Ullem
Corporate VP & CFO10.8yrsUS$5.95m0.046%
€ 18.5m
Donald Bobo
Corporate Vice President of Strategy & Corporate Development8.8yrsUS$4.29m0.035%
€ 14.0m
Larry Wood
Corporate VP and Group President of TAVR & Surgical Structural Heart1.8yrsUS$5.40m0.030%
€ 12.1m
Andrew Dahl
Principal Accounting Officerless than a yearno data0.00030%
€ 119.8k
Todd Brinton
Corporate VP of Advanced Technology & Chief Scientific Officer5.8yrsno datano data
Mark Wilterding
Vice President of Investor Relationsno datano datano data
Arnold Pinkston
Corporate VP & General Counsel5.2yrsno datano data
Dirksen Lehman
Corporate Vice President of Public Affairs11.4yrsno datano data
Christine McCauley
Corporate Vice President of Human Resources12.3yrsno datano data
Gary Sorsher
Senior Vice President of Quality & Regulatory Compliance1.3yrsno datano data
Wayne Markowitz
GM & Senior VP of Surgical Structural Heart1.3yrsno data0.00021%
€ 83.8k

5.2yrs

Average Tenure

58yo

Average Age

Experienced Management: EWLS's management team is seasoned and experienced (5.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bernard Zovighian
CEO & Director1.5yrsUS$12.87m0.012%
€ 4.8m
Kieran Gallahue
Independent Director9.8yrsUS$335.06k0.012%
€ 4.9m
Paul LaViolette
Independent Director4.3yrsUS$329.97k0.0013%
€ 522.9k
Steven Loranger
Independent Director8.7yrsUS$335.06k0.012%
€ 4.8m
Leslie Heisz
Independent Director8.3yrsUS$356.42k0.0046%
€ 1.8m
Nicholas Valeriani
Independent Chairman10yrsUS$347.97k0.012%
€ 4.7m
Leslie Davis
Independent Directorless than a yearno datano data
David Feinberg
Directorless than a yearno datano data
Ramona Sequeira
Independent Director4.5yrsUS$334.97k0.0019%
€ 746.5k

4.5yrs

Average Tenure

64yo

Average Age

Experienced Board: EWLS's board of directors are considered experienced (4.5 years average tenure).